1. |
Friguglietti CU, Lin CS, Kulcsar MA. Total thyroidectomy for benign thyroid disease [J]. Laryngoscope, 2003; 113(10)∶ 1820.
|
2. |
Bellantone R, Lombardi CP, Bossola M, et al. Total thyroidectomy for management of benign thyroid disease: review of 526 cases. World J Surg, 2002; 26(12)∶1468.
|
3. |
Muller PE, Kabus S, Robens E, et al. Indications, risks, and acceptance of total thyroidectomy for multinodular benign goiter [J]. Surg Today, 2001; 31(11)∶958.
|
4. |
李樹玲. 甲狀腺外科的現狀與展望 [J]. 中國普外基礎與臨床雜志, 2003; 10(3)∶209.
|
5. |
張德恒. 碘源性甲狀腺良性疾病外科治療的再認識 [J]. 外科理論與實踐, 2003; 8(4)∶295.
|
6. |
Menegaux F, Turpin G, Dahman M, et al. Secondary thyroidectomy in patients with prior thyoid surgery for benign disease: a study of 203 cases [J]. Surgery, 1999; 125(3)∶479.
|
7. |
Reeve TS, Delbridge L, Cohen A, et al. Total thyroidectomy. The preferred option for multinodular goiter [J]. Ann Surg, 1987; 206(6)∶782.
|
8. |
Rojdmark J, Jarhult J. High long term recurrence rate after subtotal thyroidectomy for nodular goitre [J]. Eur J Surg, 1995; 161(10)∶725.
|
9. |
Kasuga Y, Sugenoya A, Kobayashi S, et al. Significance of values of thyrotropin binding inhibitor immunoglobulins and appearance of intrathyroidal lymphocytes at subtotal thyroidectomy for Graves’ disease [J]. J Am Coll Surg, 1994; 178(6)∶589.
|
10. |
Kasuga Y, Kobayashi S, Fujimori M, et al. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves’ disease [J]. Eur J Surg, 1998; 164(3)∶173.
|